Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)
Serum and tissue redox status markers. Serum MDA (a) and TAS (b) and pancreas (c) and heart (d) MDA, for the control () and diabetic (fa/fa) ZDF rats, in the initial and final times (6 weeks of vehicle or 10 mg/kg BW/day sitagliptin treatment). Comparisons between groups ( each): a - ZDF (fa/fa) versus ZDF () and b - with sita versus without sita; and for one, two or three letters, respectively. MDA, malondialdehyde; TAS, total antioxidant status.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.